E89: GDP growth negative in Q2, $SHOP layoffs, Alzheimer's fraud, Ginkgo acquires Zymergen & more
All-In with Chamath, Jason, Sacks & Friedberg
00:00
Navigating Synthetic Biology
This chapter explores the complexities and challenges in synthetic biology, focusing on the acquisition of Zymergen by Ginkgo Bioworks and the historical evolution of this field. It discusses the balance of scientific innovation, investment dynamics, and the hurdles in translating laboratory successes into viable industrial applications.
Transcript
Play full episode
